TILRAY BRANDS - SELL | USD6.5 VS. USD10 (-12%) Q2 good or bad? It depends how you look at.
TILRAY BRANDS - SELL | USD6.5 VS. USD10 (-12%)Q2 good or bad? It depends how you look at.
Revenues down 8% sequentially
Tilray can still win in Canadian recreational cannabis
Uniquely positioned to benefit from legalisation in Europe
But short term US is most promising
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.